Evaluation of HER-2 NEU oncoprotein expression as a prognostic indicator of local recurrence in conservatively treated breast cancer: A case-control study

被引:77
作者
Haffty, BG [1 ]
Brown, F [1 ]
Carter, D [1 ]
Flynn, S [1 ]
机构
[1] YALE UNIV,SCH MED,DEPT RADIOL,NEW HAVEN,CT 06510
来源
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS | 1996年 / 35卷 / 04期
关键词
conservative surgery; radiation therapy; HER-2; NEU; local recurrence;
D O I
10.1016/0360-3016(96)00150-2
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Purpose: The purpose of this study is to determine the prognostic significance of overexpression of the HER-2 neu oncoprotein with respect to local relapse following conservative surgery and radiation therapy (CS+RT). Methods and Materials: Twenty consecutive patients who sustained a local recurrence as the first and only site of failure following CS+RT comprised the case population base for this study. Only patients who received no adjuvant systemic chemotherapy or tamoxifen were selected for analysis. Following the identification of 20 consecutive local-relapse patients, the patient database was searched for 20 matching control patients who did not sustain a local relapse. Each control patient was matched to the index case with respect to age, menopausal status, follow-up, primary histology, axillary nodal status, and primary tumor size. Both index cases and the matched control group received full course radiation therapy, to a total dose of 64 Gy to the tumor bed. The paraffin-embedded blocks of the original primary tumor of the local-relapse cases and the primary tumor of 20 matched controls were processed for immunohistochemical staining of the HER-2 neu oncoprotein. Each slide was rated on the 3-point scale, 0 representing no stain, 1+ indicating light staining, and 2+ denoted heavy staining (overexpression). Results: Of the 20 index cases, with each of the matched controls, 16 were evaluable for analysis. The 4 cases that were eliminated had inadequate paraffin-embedded material in either the case or the match control for adequate staining. By design of the study, the index case group and control group had similar ages (52 years index vs. 51.4 control), follow-up (10.8 years index vs. 10.5 years control), and histologies. For the immunostaining, a value of 2+ was considered to denote high activity and overexpression, and 0 and 1+ were considered negative values. Using these criteria, a total of 9 of the 16 index cases (56%) exhibited overexpression of HER-2 neu oncoprotein, and only 3 of the 16 control cases (18%) demonstrated high immunoreactivity. The difference in immunostaining between the index and control cases was statistically significant by a Pierson chi-square analysis at the p = 0.03 level. Conclusions: In this matched case-control study, overexpression of the HER-2 neu oncoprotein appears to have prognostic significance with respect to local relapse in the conservatively treated breast. The correlation of overexpression of HER-2 neu by multivariable analysis with other prognostic factors for local recurrence warrants further investigation. The clinical implications of the study are discussed.
引用
收藏
页码:751 / 757
页数:7
相关论文
共 27 条
[1]   HER-2/NEU IN NODE-NEGATIVE BREAST-CANCER - PROGNOSTIC-SIGNIFICANCE OF OVEREXPRESSION INFLUENCED BY THE PRESENCE OF INSITU CARCINOMA [J].
ALLRED, DC ;
CLARK, GM ;
TANDON, AK ;
MOLINA, R ;
TORMEY, DC ;
OSBORNE, CK ;
GILCHRIST, KW ;
MANSOUR, EG ;
ABELOFF, M ;
EUDEY, L ;
MCGUIRE, WL .
JOURNAL OF CLINICAL ONCOLOGY, 1992, 10 (04) :599-605
[2]  
BORG A, 1990, CANCER RES, V50, P4332
[3]  
CLARK GM, 1991, CANCER RES, V51, P944
[4]  
COHEN P, 1993, LAB INVEST, V68, pA14
[5]   SIGNIFICANCE OF IPSILATERAL BREAST-TUMOR RECURRENCE AFTER LUMPECTOMY [J].
FISHER, B ;
ANDERSON, S ;
FISHER, ER ;
REDMOND, C ;
WICKERHAM, DL ;
WOLMARK, N ;
MAMOUNAS, EP ;
DEUTSCH, M ;
MARGOLESE, R .
LANCET, 1991, 338 (8763) :327-331
[6]   8-YEAR RESULTS OF A RANDOMIZED CLINICAL-TRIAL COMPARING TOTAL MASTECTOMY AND LUMPECTOMY WITH OR WITHOUT IRRADIATION IN THE TREATMENT OF BREAST-CANCER [J].
FISHER, B ;
REDMOND, C ;
POISSON, R ;
MARGOLESE, R ;
WOLMARK, N ;
WICKERHAM, L ;
FISHER, E ;
DEUTSCH, M ;
CAPLAN, R ;
PILCH, Y ;
GLASS, A ;
SHIBATA, H ;
LERNER, H ;
TERZ, J ;
SIDOROVICH, L .
NEW ENGLAND JOURNAL OF MEDICINE, 1989, 320 (13) :822-828
[7]   BREAST RECURRENCE FOLLOWING CONSERVATIVE SURGERY AND RADIATION - PATTERNS OF FAILURE, PROGNOSIS, AND PATHOLOGICAL FINDINGS FROM MASTECTOMY SPECIMENS WITH IMPLICATIONS FOR TREATMENT [J].
FOWBLE, B ;
SOLIN, LJ ;
SCHULTZ, DJ ;
RUBENSTEIN, J ;
GOODMAN, RL .
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 1990, 19 (04) :833-842
[8]   10 YEAR RESULTS OF CONSERVATIVE SURGERY AND IRRADIATION FOR STAGE-I AND STAGE-II BREAST-CANCER [J].
FOWBLE, BL ;
SOLIN, LJ ;
SCHULTZ, DJ ;
GOODMAN, RL .
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 1991, 21 (02) :269-277
[9]   C-ERBB-2 PROTEIN OVEREXPRESSION IN BREAST-CANCER IS A RISK FACTOR IN PATIENTS WITH INVOLVED AND UNINVOLVED LYMPH-NODES [J].
GULLICK, WJ ;
LOVE, SB ;
WRIGHT, C ;
BARNES, DM ;
GUSTERSON, B ;
HARRIS, AL ;
ALTMAN, DG .
BRITISH JOURNAL OF CANCER, 1991, 63 (03) :434-438
[10]   Ipsilateral breast tumor recurrence as a predictor of distant disease: Implications for systemic therapy at the time of local relapse [J].
Haffty, BG ;
Reiss, M ;
Beinfield, M ;
Fischer, D ;
Ward, B ;
McKhann, C .
JOURNAL OF CLINICAL ONCOLOGY, 1996, 14 (01) :52-57